NL8503097A - Geneesmiddel met thrombolytische werking. - Google Patents

Geneesmiddel met thrombolytische werking. Download PDF

Info

Publication number
NL8503097A
NL8503097A NL8503097A NL8503097A NL8503097A NL 8503097 A NL8503097 A NL 8503097A NL 8503097 A NL8503097 A NL 8503097A NL 8503097 A NL8503097 A NL 8503097A NL 8503097 A NL8503097 A NL 8503097A
Authority
NL
Netherlands
Prior art keywords
urokinase
plasminogen activator
type
medicament
combination
Prior art date
Application number
NL8503097A
Other languages
English (en)
Dutch (nl)
Original Assignee
Leuven Res & Dev Vzw
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leuven Res & Dev Vzw filed Critical Leuven Res & Dev Vzw
Priority to NL8503097A priority Critical patent/NL8503097A/nl
Priority to ZA868464A priority patent/ZA868464B/xx
Priority to DK532886A priority patent/DK164640C/da
Priority to IL80538A priority patent/IL80538A/xx
Priority to NZ218231A priority patent/NZ218231A/xx
Priority to IE296286A priority patent/IE59387B1/en
Priority to AU65031/86A priority patent/AU586713B2/en
Priority to CA000522568A priority patent/CA1303987C/en
Priority to PH34452A priority patent/PH23192A/en
Priority to AT86115665T priority patent/ATE64532T1/de
Priority to PT83721A priority patent/PT83721B/pt
Priority to ES198686115665T priority patent/ES2039194T3/es
Priority to JP61269506A priority patent/JPH089546B2/ja
Priority to EP86115665A priority patent/EP0223192B1/de
Priority to DE8686115665T priority patent/DE3679887D1/de
Priority to HU864649A priority patent/HU196715B/hu
Publication of NL8503097A publication Critical patent/NL8503097A/nl
Priority to US07/384,117 priority patent/US5174994A/en
Priority to GR91400921T priority patent/GR3002226T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/49—Urokinase; Tissue plasminogen activator
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NL8503097A 1985-11-11 1985-11-11 Geneesmiddel met thrombolytische werking. NL8503097A (nl)

Priority Applications (18)

Application Number Priority Date Filing Date Title
NL8503097A NL8503097A (nl) 1985-11-11 1985-11-11 Geneesmiddel met thrombolytische werking.
ZA868464A ZA868464B (en) 1985-11-11 1986-11-06 Pharmaceutical composition having thrombolytic activity
DK532886A DK164640C (da) 1985-11-11 1986-11-07 Farmaceutisk praeparat med thrombolytisk aktivitet og fremgangsmaade til fremstilling deraf
IL80538A IL80538A (en) 1985-11-11 1986-11-07 Pharmaceutical composition having thrombolytic activity
NZ218231A NZ218231A (en) 1985-11-11 1986-11-10 Composition containing synergistic combination of plasminogen activator and urokinase activator
IE296286A IE59387B1 (en) 1985-11-11 1986-11-10 Pharmaceutical composition having thrombolytic activity
AU65031/86A AU586713B2 (en) 1985-11-11 1986-11-10 Pharmaceutical composition having thrombolytic activity
CA000522568A CA1303987C (en) 1985-11-11 1986-11-10 Pharmaceutical composition having thrombolytic activity
PH34452A PH23192A (en) 1985-11-11 1986-11-10 Pharmaceutical compositions having thrombolytic activity
AT86115665T ATE64532T1 (de) 1985-11-11 1986-11-11 Pharmazeutische zusammensetzung mit thrombolytischer wirkung.
PT83721A PT83721B (pt) 1985-11-11 1986-11-11 Processo de preparacao de composicoes farmaceuticas a base de activadores de plasminogenio com actividade trombolitica
ES198686115665T ES2039194T3 (es) 1985-11-11 1986-11-11 Un metodo de preparar una composicion farmaceutica tromboliticamente activa.
JP61269506A JPH089546B2 (ja) 1985-11-11 1986-11-11 抗血栓医薬組成物
EP86115665A EP0223192B1 (de) 1985-11-11 1986-11-11 Pharmazeutische Zusammensetzung mit thrombolytischer Wirkung
DE8686115665T DE3679887D1 (de) 1985-11-11 1986-11-11 Pharmazeutische zusammensetzung mit thrombolytischer wirkung.
HU864649A HU196715B (en) 1985-11-11 1986-11-11 Process for producing pharmaceutical compositions with thrombolytic effect
US07/384,117 US5174994A (en) 1985-11-11 1989-07-21 Pharmaceutical composition having thrombolytic activity
GR91400921T GR3002226T3 (en) 1985-11-11 1991-07-02 Pharmaceutical composition having thrombolytic activity

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NL8503097 1985-11-11
NL8503097A NL8503097A (nl) 1985-11-11 1985-11-11 Geneesmiddel met thrombolytische werking.

Publications (1)

Publication Number Publication Date
NL8503097A true NL8503097A (nl) 1987-06-01

Family

ID=19846844

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8503097A NL8503097A (nl) 1985-11-11 1985-11-11 Geneesmiddel met thrombolytische werking.

Country Status (17)

Country Link
EP (1) EP0223192B1 (de)
JP (1) JPH089546B2 (de)
AT (1) ATE64532T1 (de)
AU (1) AU586713B2 (de)
CA (1) CA1303987C (de)
DE (1) DE3679887D1 (de)
DK (1) DK164640C (de)
ES (1) ES2039194T3 (de)
GR (1) GR3002226T3 (de)
HU (1) HU196715B (de)
IE (1) IE59387B1 (de)
IL (1) IL80538A (de)
NL (1) NL8503097A (de)
NZ (1) NZ218231A (de)
PH (1) PH23192A (de)
PT (1) PT83721B (de)
ZA (1) ZA868464B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8623823D0 (en) * 1986-10-03 1986-11-05 Sandoz Ltd Therapeutic lysis of fibrin blood clots
SE462829B (sv) * 1989-01-10 1990-09-10 Kabigen Ab Trombolytiskt aktiva kompositioner innehaallande en modifierad plasminogenaktivator av vaevnadstyp samt en normal human t-pa, streptokinas eller humant urokinas
JPH05501855A (ja) * 1989-05-17 1993-04-08 リサーチ、コーポレーション、テクノロジーズ、インコーポレーテッド 哺乳動物における血栓症の治療に関する方法及び組成物
GB8919803D0 (en) * 1989-09-01 1989-10-18 Ciba Geigy Pharmaceutical compositions

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1642612A1 (de) * 1967-03-02 1971-09-09 Bayer Ag Die Verwendung von Erythrozyten zur Gewinnung bzw.Isolierung eines Plasminogen-Aktivators
NL8003402A (nl) * 1980-06-11 1982-01-04 Leuven Res & Dev Vzw Nieuwe plasminogeen-activator en farmaceutisch preparaat met trombolytische werking.
MX197183A (es) * 1982-05-05 1994-02-28 Genentech Inc Activador de plasminogeno de tejido humano
JPS5951220A (ja) * 1982-08-02 1984-03-24 Asahi Chem Ind Co Ltd 新規なプラスミノ−ゲン・アクチベ−タ−およびその製法ならびにこれを含有する薬剤
JPH0637398B2 (ja) * 1982-10-29 1994-05-18 三井東圧化学株式会社 血栓溶解剤
JPS59139323A (ja) * 1983-01-28 1984-08-10 Green Cross Corp:The ウロキナ−ゼ乾燥製剤
JPS6051119A (ja) * 1983-08-30 1985-03-22 Green Cross Corp:The ウロキナ−ゼ乾燥製剤
JPS60152421A (ja) * 1984-01-23 1985-08-10 Sanwa Kagaku Kenkyusho:Kk ヒト胎盤性プラスミノ−ゲン活性化因子、及びそれとヒトプラスミノ−ゲン活性化阻害因子との結合物、及びそれらの製法
GB8430253D0 (en) * 1984-11-30 1985-01-09 Beecham Group Plc Compounds
ATE142502T1 (de) * 1986-05-15 1996-09-15 Univ Emory Injizierbares arzneimittel zum schutz vor gewebebeschädigung durch ischemie
HUT47032A (en) * 1986-10-03 1989-01-30 Sandoz Ag Process for production of medical compositions dissolving blood cut

Also Published As

Publication number Publication date
IE862962L (en) 1987-05-11
ES2039194T3 (es) 1993-09-16
CA1303987C (en) 1992-06-23
HU196715B (en) 1989-01-30
DK164640C (da) 1992-12-14
IL80538A (en) 1991-06-30
AU6503186A (en) 1987-05-14
DK532886A (da) 1987-05-12
PT83721B (pt) 1988-08-17
DK164640B (da) 1992-07-27
EP0223192B1 (de) 1991-06-19
PH23192A (en) 1989-05-29
IE59387B1 (en) 1994-02-23
ATE64532T1 (de) 1991-07-15
JPS62155222A (ja) 1987-07-10
ZA868464B (en) 1987-06-24
DE3679887D1 (de) 1991-07-25
JPH089546B2 (ja) 1996-01-31
NZ218231A (en) 1988-10-28
IL80538A0 (en) 1987-02-27
DK532886D0 (da) 1986-11-07
GR3002226T3 (en) 1992-12-30
HUT43794A (en) 1987-12-28
EP0223192A1 (de) 1987-05-27
PT83721A (en) 1986-12-01
AU586713B2 (en) 1989-07-20

Similar Documents

Publication Publication Date Title
Goldhaber et al. Acute pulmonary embolism treated with tissue plasminogen activator
JP2766986B2 (ja) 動脈の血栓症的閉塞または塞栓症を阻止するための医薬組成物
Gold et al. Acute coronary reocclusion after thrombolysis with recombinant human tissue-type plasminogen activator: prevention by a maintenance infusion.
Van de Werf et al. Coronary thrombolysis with recombinant single-chain urokinase-type plasminogen activator in patients with acute myocardial infarction.
US4970159A (en) Human tissue plasminogen activator consisting essentially of t-PA residues 160 to 527
Tamao et al. Effect of a selective thrombin inhibitor MCI-9038 on fibrinolysis in vitro and in vivo
Been et al. Clinical effects and kinetic properties of intravenous APSAC—anisoylated plasminogen-streptokinase activator complex (BRL 26921) in acute myocardial infarction
Bode et al. Efficacy of intravenous prourokinase and a combination of prourokinase and urokinase in acute myocardial infarction
Ambrus et al. On the mechanism of thrombolysis by plasmin
NL8200004A (nl) Gestabiliseerde plasmine samenstellingen en werkwijze voor de bereiding ervan.
Gurewich Experiences with pro-urokinase and potentiation of its fibrinolytic effect by urokinase and by tissue plasminogen activator
Topol et al. Thrombolysis with recombinant tissue plasminogen activator in atherosclerotic thrombotic occlusion
Gans Thrombogenic properties of epsilon amino caproic acid
Collen et al. Synergistic effect on thrombolysis of sequential infusion of tissue-type plasminogen activator (t-PA) single-chain urokinase-type plasminogen activator (scu-PA) and urokinase in the rabbit jugular vein thrombosis model
NL8503097A (nl) Geneesmiddel met thrombolytische werking.
EP0099126B1 (de) Thrombolytische Zusammensetzung
Bergstein et al. Tissue plasminogen activator therapy of glomerular thrombi in the Shwartzman reaction
Leaker et al. Fibrin clot lysis by tissue plasminogen activator (tPA) is impaired in plasma from pediatric patients undergoing orthotopic liver transplantation
Pilger et al. Intraarterial fibrinolysis: in vitro and prospective clinical evaluation of three thrombolytic agents.
US5174994A (en) Pharmaceutical composition having thrombolytic activity
de Wit Investigations on the inhibitors of the fibrinolytic system
Voytika et al. The beneficial effect of lys-plasminogen upon the thrombolytic efficacy of urokinase in a dog model of peripheral arterial thrombosis
EP0381640B1 (de) Thrombotische Zusammensetzungen
Barlow et al. Plasma urokinase levels measured by chromogenic assay after infusions of tissue culture or urinary source material
Roschlau et al. Human fibrinolysin with and without urokinase: Its effect on experimental arterial thrombi in dogs

Legal Events

Date Code Title Description
A1B A search report has been drawn up
BV The patent application has lapsed